series-c-plus
Stage
3
Investors
About
Vedanta Biosciences develops oral live biotherapeutic products composed of defined bacterial consortia to treat serious gastrointestinal diseases such as recurrent Clostridium difficile infection.
Explore Vedanta Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.